Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus

Documenti analoghi

• Immunological Reactivity of Blood from Healthy Humans to the rAls3p-N Vaccine Protein
  di: Baquir, Beverlie, et al.
  Pubblicazione: (2010)
• Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
  di: Lin, Lin, et al.
  Pubblicazione: (2009)
• Considerable Differences in Vaccine Immunogenicities and Efficacies Related to the Diluent Used for Aluminum Hydroxide Adjuvant
  di: Lin, Lin, et al.
  Pubblicazione: (2008)
• Safety and Efficacy of Activated Transfected Killer Cells for Neutropenic Fungal Infections
  di: Lin, Lin, et al.
  Pubblicazione: (2010)
• The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus
  di: Spellberg, Brad, et al.
  Pubblicazione: (2008)